Market Tracker

12/11 5:15pm ET

Meridian Bioscience Inc (NASDAQ:VIVO)

14.15
Delayed Data
As of 4:00pm ET
 +0.05 / +0.35%
Today’s Change
10.75
Today|||52-Week Range
18.58
-20.06%
Year-to-Date
No recent news for Meridian Bioscience Inc.

Today’s Trading

Previous close14.10
Today’s open14.10
Day’s range14.10 - 14.50
Volume327,784
Average volume (3 months)236,340
Market cap$595.3M
Dividend yield3.53%
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-32.89%
Earnings growth (this year)-1.28%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+2.39%
P/E ratio27.7
Price/Sales3.03
Price/Book3.51

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.75-7.89%
LNTHLantheus Holdings In...-0.30-1.44%
----
OXFDOxford Immunotec Glo...-0.59-4.33%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.15
Annual revenue (last year)$200.8M
Annual profit (last year)$21.6M
Net profit margin10.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John P. Kenny
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts